Primary and Secondary Prevention of Cardiovascular Disease
Cardiovascular disease is the leading cause of death globally and recent statistics indicate that the decline in mortality observed in the last few decades is stagnating and even reversing in some populations. Robust research and evidence-based preventive strategies are increasingly necessary to reduce the global burden of this disease. This PLOS ONE collection highlights rigorous research focused on the primary and secondary prevention of cardiovascular disease.
Image Credit: Kirsty Pargeter
-
Guest Editor, PLOS ONE Maryam Kavousi
-
Guest Editor, PLOS ONE Jemma C. Hopewell
-
Guest Editor, PLOS ONE Jennifer G. Robinson
-
Guest Editor, PLOS ONE Martin O’Flaherty
-
Guest Editor, PLOS ONE Dominique Hansen
-
Guest Editor, PLOS ONE Yangfeng Wu
-
Guest Editor, PLOS ONE Clara Chow
-
Guest Editor, PLOS ONE Michael D. Shapiro
-
Image creditBlood Pressure by Gerald Oswald, Pixabay License
-
PLOS ONE Ten-years cardiovascular risk among Bangladeshi population using non-laboratory-based risk chart of the World Health Organization: Findings from a nationally representative survey
The World Health Organization (WHO) has recently developed a non-laboratory based cardiovascular disease (CVD) risk chart considering the…
-
PLOS ONE Long-term exposure to outdoor air pollution and risk factors for cardiovascular disease within a cohort of older men in Perth
While there is clear evidence that high levels of pollution are associated with increased all-cause mortality and cardiovascular mortality…
-
PLOS ONE Patients’ experiences of the complex trust-building process within digital cardiac rehabilitation
The development of digital solutions is becoming increasingly important in facing global challenges. Therefore, research on this topic is…
-
PLOS ONE Prevalence of low high-density lipoprotein among young adults receiving antiretroviral therapy in Zambia: An opportunity to consider non-communicable diseases in resource-limited settings
Background: With the introduction of effective antiretroviral therapy (ART), people living with HIV (PLWH) are surviving longer and are at…
-
Image creditKidney Disease by Nephron, CC BY-SA 4.0PLOS ONE Chronic kidney disease and the outcomes of fibrinolysis for ST-segment elevation myocardial infarction: A real-world study
Background: In low-resource regions, fibrinolytic therapy is often the only option for ST-elevation myocardial infarction (STEMI) patients…
-
PLOS ONE A qualitative, grounded theory exploration of the determinants of self-care behavior among Indian patients with a lived experience of chronic heart failure
Background: Prior reports have documented extremely poor adherence to evidence-based medications among South Asian patients with…
-
PLOS ONE Ten-year cardiovascular risk among cancer survivors: The National Health and Nutrition Examination Survey
Background: Cancer survivors have a higher risk of developing and dying from cardiovascular disease (CVD) compared to the general…